Abstract
Familial hypercholesterolemia (FH) is a common autosomal dominant inherited disorder characterized by increased levels of circulating plasma low-density lipoprotein cholesterol (LDL-C), tendon xanthomas, and premature atherosclerotic cardiovascular disease. Homozygous FH occurs in only one in a million people. Focal segmental glomerulosclerosis (FSGS) is clinically characterized by proteinuria, which is marked in the majority of cases and accompanied by nephrotic syndrome, high incidence of hypertension, and progression to renal failure. To our knowledge, we herein report for the first time a case of homozygous FH associated with FSGS. A seven-and-a-half-year-old boy was referred to our hospital due to cutaneous xanthomata and growth retardation. He had multiple nodular yellowish cutaneous xanthomatous lesions each 1 cm in size over his knees and sacral region. Laboratory data included cholesterol level of 1,050 mg/dl, low density lipoprotein cholesterol (LDL-C) 951 mg/dl, high-density lipoprotein cholesterol (HDL-C) 29 mg/dl, triglycerides 168 mg/dl, total protein 6.3 g/dl, and albumin 3.2 g/dl. Urinary protein excretion was 78 mg/m2 per hour. A percutaneous renal biopsy was performed, and histological findings showed FSGS. Treatment with cholestyramine and atorvastatin was unsuccessful in terms of lowering lipids, and he was placed on weekly sessions of plasmapheresis. Total cholesterol was reduced from 1,050 mg/dl to 223 mg/dl, LDL-C from 951 mg/dl to 171 mg/dl, and urinary protein excretion from 78 mg/m2 per hour to 42 mg/m2 per hour after eight sessions of plasmapheresis. It is our belief that plasmapheresis is a treatment of choice in patients with FSGS associated with FH.
References
Goldstein JL, Brown MS (1995) Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 1981–2030
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106:3143–3421
Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343:425–430
Goldstein JL, Brown MS (2001) Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 8th edn. McGraw-Hill, New York, pp 2863–2901
Keane WF (1994) Lipids and the kidney. Kidney Int 46:910–920
Moorhead JF, Wheeler DC, Varghese Z (1989) Glomerular structures and lipids in progressive renal disease. Am J Med 87:5–12
Asami T, Hayakawa H, Ohkawa K, Uchiyama M (1999) Hypercholesterolemia and glomerular disease in urinary screening of school children. Pediatr Nephrol 13:125–128
Yagi K, Hifumi S, Nohara A, Higashikata T, Inazu A, Mizuno K, Namura M, Ueda K, Kobayashi J, Shimizu M, Mabuchi H (2004) Difference in the risk factors for coronary, renal and other peripheral arteriosclerosis in heterozygous familial hypercholesterolemia. Circ J 68:623–627
Yokoyoma S, Yamamoto A, Hayashi R, Satani M (1987) LDL-apheresis; potential procedure for prevention and regression of atheromatous vascular lesion. Jpn Circ J 51:1116–1122
Bilheimer DW, Goldstein JL, Grundy SM, Brown MS (1975) Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia. J Clin Invest 56:1420–1430
Bilheimer DW (1989) Portacaval shunt and liver transplantation in treatment of familial hypercholesterolemia. Arteriosclerosis 9:1158–1163
Starzl TE, Putnam CW, Koep LJ (1978) Portacaval shunt and hyperlipidemia. Arch Surg 113:71–74
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Elmaci, A.M., Peru, H., Akin, F. et al. A case of homozygous familial hypercholesterolemia with focal segmental glomerulosclerosis. Pediatr Nephrol 22, 1803–1805 (2007). https://doi.org/10.1007/s00467-007-0534-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-007-0534-y